What is Chemed Corp's earnings per share (EPS)?

Chemed Corp (CHE) reported diluted earnings per share of $18.34 for fiscal year 2025. This represents a -7.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Chemed Corp Financials

CHE

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Chemed Corp (CHE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 54/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Chemed Corp has an operating margin of 13.4%, meaning the company retains $13 of operating profit per $100 of revenue. This results in a moderate score of 52/100, indicating healthy but not exceptional operating efficiency. This is down from 15.1% the prior year.

Growth

Chemed Corp's revenue grew a modest 4.1% year-over-year to $2.5B. This slow but positive growth earns a score of 40/100.

Leverage

Chemed Corp carries a low D/E ratio of 0.57, meaning only $0.57 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Chemed Corp's current ratio of 1.05 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 16/100, which could limit financial flexibility.

Cash Flow

Chemed Corp has a free cash flow margin of 12.9%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Chemed Corp earns a strong 27.1% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 71/100. This is up from 27.0% the prior year.

Altman Z-Score Safe

10.70

Chemed Corp scores 10.70, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.2B) relative to total liabilities ($558.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Chemed Corp passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.46x

For every $1 of reported earnings, Chemed Corp generates $1.46 in operating cash flow ($388.3M OCF vs $265.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

193.3x

Chemed Corp earns $193.3 in operating income for every $1 of interest expense ($338.2M vs $1.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5B

YoY+4.1%

5Y CAGR+4.0%

10Y CAGR+5.1%

Chemed Corp generated $2.5B in revenue in fiscal year 2025. This represents an increase of 4.1% from the prior year.

EBITDA

$403.1M

YoY-6.2%

5Y CAGR-2.0%

10Y CAGR+6.3%

Chemed Corp's EBITDA was $403.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.2% from the prior year.

Net Income

$265.2M

YoY-12.2%

5Y CAGR-3.7%

10Y CAGR+9.2%

Chemed Corp reported $265.2M in net income in fiscal year 2025. This represents a decrease of 12.2% from the prior year.

EPS (Diluted)

$18.34

YoY-7.8%

5Y CAGR-1.2%

10Y CAGR+11.2%

Chemed Corp earned $18.34 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 7.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$325.5M

YoY-11.5%

5Y CAGR-5.4%

10Y CAGR+9.8%

Chemed Corp generated $325.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 11.5% from the prior year.

Cash & Debt

$74.5M

YoY-58.2%

5Y CAGR-14.5%

10Y CAGR+17.6%

Chemed Corp held $74.5M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.20

YoY+22.2%

5Y CAGR+10.8%

10Y CAGR+9.1%

Chemed Corp paid $2.20 per share in dividends in fiscal year 2025. This represents an increase of 22.2% from the prior year.

Shares Outstanding

14M

YoY-6.0%

5Y CAGR-3.0%

Chemed Corp had 14M shares outstanding in fiscal year 2025. This represents a decrease of 6.0% from the prior year.

Margins & Returns

Gross Margin

32.5%

YoY-2.6pp

5Y CAGR-1.2pp

10Y CAGR+3.0pp

Chemed Corp's gross margin was 32.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.6 percentage points from the prior year.

Operating Margin

13.4%

YoY-1.7pp

5Y CAGR-5.4pp

10Y CAGR+1.4pp

Chemed Corp's operating margin was 13.4% in fiscal year 2025, reflecting core business profitability. This is down 1.7 percentage points from the prior year.

Net Margin

10.5%

YoY-1.9pp

5Y CAGR-4.9pp

10Y CAGR+3.3pp

Chemed Corp's net profit margin was 10.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.9 percentage points from the prior year.

Return on Equity

27.1%

YoY+0.1pp

5Y CAGR-8.4pp

10Y CAGR+5.6pp

Chemed Corp's ROE was 27.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$431.5M

YoY+19.4%

5Y CAGR+19.7%

10Y CAGR+21.9%

Chemed Corp spent $431.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 19.4% from the prior year.

Capital Expenditures

$62.8M

YoY+26.8%

5Y CAGR+1.3%

10Y CAGR+3.6%

Chemed Corp invested $62.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 26.8% from the prior year.

CHE Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$2.5B+4.1%	$2.4B+7.4%	$2.3B+6.1%	$2.1B-0.2%	$2.1B+2.9%	$2.1B
Cost of Revenue	$1.7B+8.2%	$1.6B+7.6%	$1.5B+7.0%	$1.4B0.0%	$1.4B-0.6%	$1.4B
Gross Profit	$823.2M-3.6%	$854.3M+7.0%	$798.8M+4.4%	$765.1M-0.6%	$769.8M+9.8%	$701.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$417.2M-1.7%	$424.4M+7.4%	$395.1M+10.1%	$358.7M-2.2%	$366.7M+11.1%	$330.2M
Operating Income	$338.2M-7.7%	$366.5M+7.6%	$340.6M-0.9%	$343.5M+0.1%	$343.0M-12.0%	$389.7M
Interest Expense	$1.8M-1.7%	$1.8M-42.7%	$3.1M-32.2%	$4.6M+145.4%	$1.9M-20.7%	$2.4M
Income Tax	$90.5M-7.1%	$97.5M+25.2%	$77.9M-2.7%	$80.1M-2.1%	$81.8M+6.8%	$76.5M
Net Income	$265.2M-12.2%	$302.0M+10.8%	$272.5M+9.2%	$249.6M-7.0%	$268.6M-15.9%	$319.5M
EPS (Diluted)	$18.34-7.8%	$19.89+10.9%	$17.93+8.5%	$16.53-1.9%	$16.85-13.5%	$19.48

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$639.3M+2.3%	$624.9M+1.0%	$618.8M-4.4%	$646.9M+1.1%	$640.0M+5.6%	$606.2M+1.7%	$595.9M+1.1%	$589.2M
Cost of Revenue	$414.2M-3.2%	$428.0M-1.4%	$434.1M+0.8%	$430.5M+6.1%	$405.9M+2.4%	$396.2M+1.7%	$389.8M+1.2%	$385.1M
Gross Profit	$225.2M+14.4%	$196.9M+6.6%	$184.7M-14.7%	$216.4M-7.6%	$234.1M+11.5%	$210.0M+1.9%	$206.1M+1.0%	$204.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$105.5M-0.3%	$105.8M+5.4%	$100.3M-5.0%	$105.6M+1.3%	$104.3M+2.2%	$102.0M-0.3%	$102.3M-11.8%	$115.9M
Operating Income	$100.7M+34.7%	$74.8M+9.8%	$68.1M-28.1%	$94.8M-16.8%	$113.9M+23.6%	$92.2M+4.6%	$88.1M+21.8%	$72.3M
Interest Expense	$521K+14.0%	$457K+3.2%	$443K+34.7%	$329K-34.1%	$499K+16.9%	$427K-0.5%	$429K+0.9%	$425K
Income Tax	$28.7M+48.6%	$19.3M+3.7%	$18.6M-22.1%	$23.9M-19.8%	$29.8M+18.0%	$25.3M+10.1%	$22.9M+17.8%	$19.5M
Net Income	$76.8M+19.5%	$64.2M+22.4%	$52.5M-26.8%	$71.8M-20.6%	$90.3M+19.2%	$75.8M+6.9%	$70.9M+9.0%	$65.0M
EPS (Diluted)	N/A	$4.46+24.9%	$3.57-26.5%	$4.86	N/A	$5.00+7.5%	$4.65+9.7%	$4.24

CHE Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.5B-7.8%	$1.7B0.0%	$1.7B+15.7%	$1.4B+7.4%	$1.3B-6.4%	$1.4B
Current Assets	$302.6M-23.3%	$394.7M-21.2%	$500.8M+83.7%	$272.6M+18.4%	$230.3M-30.1%	$329.4M
Cash & Equivalents	$74.5M-58.2%	$178.3M-32.4%	$264.0M+256.1%	$74.1M+125.3%	$32.9M-79.8%	$162.7M
Inventory	$7.5M-7.9%	$8.2M-31.7%	$12.0M+16.9%	$10.3M+1.6%	$10.1M+42.5%	$7.1M
Accounts Receivable	$182.6M+6.7%	$171.2M-5.7%	$181.5M+30.2%	$139.4M+1.6%	$137.2M+8.2%	$126.9M
Goodwill	$667.0M0.0%	$666.7M+14.0%	$585.0M+0.6%	$581.3M+0.5%	$578.6M0.0%	$578.6M
Total Liabilities	$558.8M+1.7%	$549.6M-1.9%	$560.2M-12.9%	$643.3M-10.6%	$719.5M+34.8%	$533.7M
Current Liabilities	$287.1M+0.5%	$285.7M-8.4%	$312.1M+5.0%	$297.2M-1.7%	$302.4M+1.1%	$299.1M
Long-Term Debt	N/A	N/A	N/A	$92.5M-50.0%	$185.0M	N/A
Total Equity	$979.4M-12.5%	$1.1B+1.0%	$1.1B+38.7%	$798.7M+28.1%	$623.3M-30.8%	$901.2M
Retained Earnings	$3.0B+8.6%	$2.7B+11.2%	$2.4B+11.3%	$2.2B+11.6%	$2.0B+14.3%	$1.7B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$1.5B-5.3%	$1.6B-5.5%	$1.7B-0.5%	$1.7B+3.5%	$1.7B-5.7%	$1.8B+2.0%	$1.7B+0.4%	$1.7B
Current Assets	$302.6M-23.4%	$395.2M-19.6%	$491.4M-2.2%	$502.4M+27.3%	$394.7M-19.5%	$490.4M+5.6%	$464.6M-13.9%	$539.6M
Cash & Equivalents	$74.5M-42.6%	$129.8M-48.1%	$249.9M+43.7%	$173.9M-2.5%	$178.3M-25.2%	$238.5M+7.0%	$222.9M-28.9%	$313.4M
Inventory	$7.5M-8.4%	$8.2M-9.9%	$9.1M+17.4%	$7.8M-4.9%	$8.2M-17.2%	$9.9M-7.8%	$10.7M+0.2%	$10.7M
Accounts Receivable	$182.6M-15.3%	$215.6M+16.6%	$184.9M-35.3%	$285.9M+67.0%	$171.2M-12.9%	$196.5M+6.2%	$185.0M+4.3%	$177.3M
Goodwill	$667.0M0.0%	$667.0M0.0%	$667.0M0.0%	$666.9M0.0%	$666.7M0.0%	$666.9M+0.7%	$662.1M+11.9%	$591.5M
Total Liabilities	$558.8M+2.2%	$546.9M+5.3%	$519.4M-4.7%	$544.8M-0.9%	$549.6M+3.0%	$533.7M+1.1%	$527.7M-3.0%	$544.1M
Current Liabilities	$287.1M-1.7%	$292.0M+10.7%	$263.9M-9.2%	$290.6M+1.7%	$285.7M+7.9%	$264.8M+1.2%	$261.8M-7.2%	$282.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$979.4M-9.0%	$1.1B-10.2%	$1.2B+1.4%	$1.2B+5.6%	$1.1B-9.4%	$1.2B+2.4%	$1.2B+2.0%	$1.2B
Retained Earnings	$3.0B+2.4%	$2.9B+2.0%	$2.8B+1.6%	$2.8B+2.4%	$2.7B+3.1%	$2.6B+2.7%	$2.6B+2.6%	$2.5B

CHE Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$388.3M-7.0%	$417.5M+26.4%	$330.3M+6.6%	$309.9M+0.4%	$308.6M-36.9%	$489.3M
Capital Expenditures	$62.8M+26.8%	$49.5M-12.9%	$56.9M-0.8%	$57.3M-2.3%	$58.7M-0.3%	$58.8M
Free Cash Flow	$325.5M-11.5%	$368.0M+34.6%	$273.4M+8.3%	$252.6M+1.1%	$249.9M-41.9%	$430.5M
Investing Cash Flow	-$59.3M+58.8%	-$143.9M-137.3%	-$60.6M-2.1%	-$59.4M-2.8%	-$57.8M+6.2%	-$61.6M
Financing Cash Flow	-$432.8M-20.5%	-$359.2M-350.0%	-$79.8M+61.9%	-$209.3M+45.0%	-$380.6M-40.3%	-$271.2M
Dividends Paid	$31.7M+17.0%	$27.1M+15.3%	$23.5M+6.7%	$22.0M0.0%	$22.0M+4.4%	$21.1M
Share Buybacks	$431.5M+19.4%	$361.4M+433.8%	$67.7M-40.9%	$114.5M-80.1%	$576.0M+228.1%	$175.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$133.5M+60.1%	$83.4M-39.8%	$138.6M+323.3%	$32.7M-80.1%	$164.9M+82.2%	$90.5M+16.8%	$77.5M-8.3%	$84.5M
Capital Expenditures	$16.3M-6.6%	$17.5M+10.7%	$15.8M+19.1%	$13.3M+4.1%	$12.8M-31.6%	$18.6M-80.7%	$96.4M+692.8%	$12.2M
Free Cash Flow	$117.2M+77.8%	$65.9M-46.3%	$122.8M+530.9%	$19.5M-87.2%	$152.2M+111.7%	$71.9M+480.0%	-$18.9M-126.1%	$72.4M
Investing Cash Flow	-$16.0M-12.1%	-$14.2M+8.1%	-$15.5M-13.2%	-$13.7M-9.2%	-$12.5M+32.4%	-$18.5M+80.2%	-$93.5M-382.3%	-$19.4M
Financing Cash Flow	-$172.8M+8.7%	-$189.3M-301.9%	-$47.1M-100.1%	-$23.5M+88.9%	-$212.5M-276.4%	-$56.5M+24.2%	-$74.5M-372.2%	-$15.8M
Dividends Paid	$8.5M-1.8%	$8.7M+19.9%	$7.2M-1.5%	$7.3M-2.3%	$7.5M+0.1%	$7.5M+23.6%	$6.1M+0.1%	$6.0M
Share Buybacks	$174.6M-3.4%	$180.8M+320.9%	$42.9M+29.3%	$33.2M-84.1%	$209.3M+262.0%	$57.8M+3.7%	$55.8M+45.0%	$38.5M

CHE Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	32.5%-2.6pp	35.1%-0.1pp	35.3%-0.6pp	35.8%-0.1pp	36.0%+2.3pp	33.7%
Operating Margin	13.4%-1.7pp	15.1%+0.0pp	15.0%-1.0pp	16.1%+0.1pp	16.0%-2.7pp	18.7%
Net Margin	10.5%-1.9pp	12.4%+0.4pp	12.0%+0.3pp	11.7%-0.9pp	12.6%-2.8pp	15.4%
Return on Equity	27.1%+0.1pp	27.0%+2.4pp	24.6%-6.7pp	31.3%-11.8pp	43.1%+7.6pp	35.4%
Return on Assets	17.2%-0.9pp	18.1%+1.8pp	16.3%-1.0pp	17.3%-2.7pp	20.0%-2.3pp	22.3%
Current Ratio	1.05-0.3	1.38-0.2	1.60+0.7	0.92+0.2	0.76-0.3	1.10
Debt-to-Equity	0.57+0.1	0.49-0.0	0.51+0.4	0.12-0.2	0.30-0.3	0.59
FCF Margin	12.9%-2.3pp	15.1%+3.0pp	12.1%+0.3pp	11.8%+0.2pp	11.7%-9.0pp	20.7%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	35.2%+3.7pp	31.5%+1.7pp	29.8%-3.6pp	33.5%-3.1pp	36.6%+1.9pp	34.6%+0.1pp	34.6%-0.1pp	34.6%
Operating Margin	15.7%+3.8pp	12.0%+1.0pp	11.0%-3.6pp	14.6%-3.1pp	17.8%+2.6pp	15.2%+0.4pp	14.8%+2.5pp	12.3%
Net Margin	12.0%+1.7pp	10.3%+1.8pp	8.5%-2.6pp	11.1%-3.0pp	14.1%+1.6pp	12.5%+0.6pp	11.9%+0.9pp	11.0%
Return on Equity	7.8%+1.9pp	6.0%+1.6pp	4.4%-1.7pp	6.1%-2.0pp	8.1%+1.9pp	6.1%+0.3pp	5.9%+0.4pp	5.5%
Return on Assets	5.0%+1.0pp	4.0%+0.9pp	3.1%-1.1pp	4.2%-1.3pp	5.4%+1.1pp	4.3%+0.2pp	4.1%+0.3pp	3.8%
Current Ratio	1.05-0.3	1.35-0.5	1.86+0.1	1.73+0.3	1.38-0.5	1.85+0.1	1.77-0.1	1.91
Debt-to-Equity	0.57+0.1	0.51+0.1	0.43-0.0	0.46-0.0	0.49+0.1	0.430.0	0.44-0.0	0.46
FCF Margin	18.3%+7.8pp	10.5%-9.3pp	19.8%+16.8pp	3.0%-20.8pp	23.8%+11.9pp	11.9%+15.0pp	-3.2%-15.4pp	12.3%

Similar Companies

Option Care Health Inc OPCH

$4.3B

Davita Inc DVA

$9.7B

Ensign Group Inc ENSG

$11.4B

Amedisys Inc AMED

$3.3B

Surgery Partners Inc SGRY

$1.6B

Frequently Asked Questions

What is Chemed Corp's annual revenue?

Chemed Corp (CHE) reported $2.5B in total revenue for fiscal year 2025. This represents a 4.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Chemed Corp's revenue growing?

Chemed Corp (CHE) revenue grew by 4.1% year-over-year, from $2.4B to $2.5B in fiscal year 2025.

Is Chemed Corp profitable?

Yes, Chemed Corp (CHE) reported a net income of $265.2M in fiscal year 2025, with a net profit margin of 10.5%.

What is Chemed Corp's EBITDA?

Chemed Corp (CHE) had EBITDA of $403.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Chemed Corp's gross margin?

Chemed Corp (CHE) had a gross margin of 32.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Chemed Corp's operating margin?

Chemed Corp (CHE) had an operating margin of 13.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Chemed Corp's net profit margin?

Chemed Corp (CHE) had a net profit margin of 10.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Chemed Corp pay dividends?

Yes, Chemed Corp (CHE) paid $2.20 per share in dividends during fiscal year 2025.

What is Chemed Corp's return on equity (ROE)?

Chemed Corp (CHE) has a return on equity of 27.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Chemed Corp's free cash flow?

Chemed Corp (CHE) generated $325.5M in free cash flow during fiscal year 2025. This represents a -11.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Chemed Corp's operating cash flow?

Chemed Corp (CHE) generated $388.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Chemed Corp's total assets?

Chemed Corp (CHE) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Chemed Corp's capital expenditures?

Chemed Corp (CHE) invested $62.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Chemed Corp buy back shares?

Yes, Chemed Corp (CHE) spent $431.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Chemed Corp have outstanding?

Chemed Corp (CHE) had 14M shares outstanding as of fiscal year 2025.

What is Chemed Corp's current ratio?

Chemed Corp (CHE) had a current ratio of 1.05 as of fiscal year 2025, which is considered adequate.

What is Chemed Corp's debt-to-equity ratio?

Chemed Corp (CHE) had a debt-to-equity ratio of 0.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Chemed Corp's return on assets (ROA)?

Chemed Corp (CHE) had a return on assets of 17.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Chemed Corp's Altman Z-Score?

Chemed Corp (CHE) has an Altman Z-Score of 10.70, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Chemed Corp's Piotroski F-Score?

Chemed Corp (CHE) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Chemed Corp's earnings high quality?

Chemed Corp (CHE) has an earnings quality ratio of 1.46x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Chemed Corp cover its interest payments?

Chemed Corp (CHE) has an interest coverage ratio of 193.3x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Chemed Corp?

Chemed Corp (CHE) scores 54 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.